Cannara Biotech Inc. (TSXV: LOVE)
Canada
· Delayed Price · Currency is CAD 0.750
-0.050 (-6.25%)
Dec 20, 2024, 2:54 PM EST
Cannara Biotech Revenue
In the fiscal year ending August 31, 2024, Cannara Biotech had annual revenue of 81.75M CAD with 42.77% growth. Cannara Biotech had revenue of 23.04M in the quarter ending August 31, 2024, with 28.15% growth.
Revenue
81.75M
Revenue Growth
+42.77%
P/S Ratio
0.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
67.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb Corporation | 6.33B |
| Bausch Health Companies Inc. | 12.80B |
| WELL Health Technologies Corp. | 957.69M |
| Curaleaf Holdings, Inc. | 1.83B |
| dentalcorp Holdings Ltd. | 1.51B |
| Tilray Brands, Inc. | 1.10B |
| Sienna Senior Living Inc. | 867.55M |
| Cronos Group Inc. | 150.26M |